NCT02579642View on ClinicalTrials.gov

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Depressive Disorder
Interventions
DRUG

Ketamine

Low dose ketamine 0.2 mg/kg (or 0.5 mg/kg depending on results of interim analysis) administered with usual induction drugs for ECT

DRUG

Placebo

Normal saline administered with usual induction drugs for ECT

Trial Locations (2)

T5J 2J7

Alberta Hospital Edmonton, Edmonton

T6G 2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

lead

University of Alberta

OTHER

NCT02579642 - Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy | Biotech Hunter | Biotech Hunter